Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Tables)

v3.22.2.2
FAIR VALUE MEASUREMENTS (Tables)
 9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

  

    As of September 30, 2022     Fair Value Measurements  
    Carrying     Fair     As of September 30, 2022  
    Amount     Value     Level 1     Level 2     Level 3  
                (unaudited)              
Liabilities:                              
Contingent consideration:                                        
Asuragen (1)   $ 1,141     $ 1,141     $ -     $ -     $ 1,141  
Other accrued expenses:                                        
Warrant liability (2)     -       -       -       -       -  
Note payable:                                                       
BroadOak loan     9,988       9,988       -       -       9,988  
    $ 11,129     $ 11,129     $ -     $ -     $ 11,129  

 

(1)(2) See Note 10, Accrued Expenses and Long-Term Liabilities
(1) See Note 10, Accrued Expenses and Long-Term Liabilities
(2) See Note 10, Accrued Expenses and Long-Term Liabilities

 

    As of December 31, 2021     Fair Value Measurements  
    Carrying     Fair     As of December 31, 2021  
    Amount     Value     Level 1     Level 2     Level 3  
Liabilities:                              
Contingent consideration:                                        
Asuragen (1)   $ 1,871     $ 1,871     $ -     $ -     $ 1,871  
Other accrued expenses:                                        
Warrant liability (2)     71       71       -       -       71  
Note payable:                                        
BroadOak loan     7,942       7,942       -       -       7,942  
    $ 9,884     $ 9,884     $ -     $ -     $ 9,884  

 

(1)(2) See Note 10, Accrued Expenses and Long-Term Liabilities
(2)
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability, 2017 Underwriters’ Warrants and BroadOak loans to September 30, 2022 is as follows:

  

    December 31, 2021     Issued     Reclassified     Earned     Accretion/Interest Accrued     Adjustment to Fair Value/ Mark to Market     September 30, 2022  
    (unaudited)  
Asuragen   $ 1,871     $ -     $ -     $ (542 )   $ 123     $ (311 )   $ 1,141  
                                                         
Underwriters Warrants     71       -       -       -       -       (71 )     -  
                                                         
BroadOak loans     7,942       -       2,000       -       -       46       9,988  
                                                         
BroadOak Convertible Note     -       2,000       (2,000 )     -       -       -       -  
    $ 9,884     $ 2,000     $ -     $ (542 )   $ 123     $ (336 )   $ 11,129